NCT03271281View on ClinicalTrials.gov

PET/CT Imaging of Angiogenesis in Patients With Neuroendocrine Tumors Using 68Ga-NODAGA-E[c(RGDyK)]2

PHASE2CompletedINTERVENTIONAL
Enrollment

113

Participants

Timeline

Start Date

December 4, 2017

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Neuroendocrine Tumors
Interventions
DRUG

One injection of 68Ga-NODAGA-E[c(RGDyK)]2

One injection of 68Ga-NODAGA-E\[c(RGDyK)\]2

DEVICE

PET/CT

Following injection of 68Ga-NODAGA-E\[c(RGDyK)\]2 the patients will be subjected to whole body PET/CT

Trial Locations (1)

Unknown

Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, Copenhagen

All Listed Sponsors
lead

Rigshospitalet, Denmark

OTHER

NCT03271281 - PET/CT Imaging of Angiogenesis in Patients With Neuroendocrine Tumors Using 68Ga-NODAGA-E[c(RGDyK)]2 | Biotech Hunter | Biotech Hunter